Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,410,408
-$557,114 QoQ
Shares Held
100,100
-5.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#877
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. PFE ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
This page
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,410,408 | 100,100 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,967,522 | 105,681 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,842,110 | 114,141 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,913,663 | 114,351 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,005,711 | 123,998 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,634,592 | 143,433 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,927,983 | 110,365 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,817,243 | 131,902 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,650,354 | 130,463 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,822,673 | 137,754 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,139,771 | 143,792 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,351,515 | 161,336 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,556,029 | 151,473 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,560,272 | 160,791 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,518,239 | 205,274 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,927,652 | 204,014 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,114,478 | 211,987 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,837,490 | 190,023 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $11,630,842 | 196,966 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $8,830,555 | 205,314 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,236,924 | 184,804 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,717,802 | 185,421 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,689,444 | 181,729 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,706,551 | 182,740 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,984,171 | 183,002 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,129,718 | 187,798 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||